Fosun Pharma is a pharmaceutical company.
Fosun Pharma is a biopharmaceutical and healthcare industry. Fosun Pharma has captured opportunities within the rapidly developing Chinese healthcare industry as well as from the globalization of Chinese healthcare companies in general. Fosun Pharma's operations strategically cover several important segments of the healthcare industry value-chain, including: pharmaceutical manufacturing, distribution and retail.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Aug 2, 2022
Xingmai Technology
|
Series Unknown | ¥100M | Health Diagnostics | Yes |
Dec 10, 2018
EOS Imaging
|
Post-IPO Equity | €15M | 3D Technology | Yes |
Fosun Pharma has acquired 1 organizations. Their most recent acquisition was Gland Pharma on Jul 27, 2016. They acquired Gland Pharma for $1.40B.
Date
Company Name
|
Industry | Acquisition Type | Price | |
---|---|---|---|---|
Jul 27, 2016
Gland Pharma
|
Health Care | acquisition | $ 1.40B | Detail |